Higher MI shock survival with NCSI protocol: Final resultsApril 30, 2021Acute Coronary SyndromesHeart Failure
AHA statement flags CV risk of hormonal cancer therapiesApril 29, 2021CAD & AtherosclerosisHeart FailureStrokeLipid DisordersMixed Topics
Post–COVID-19 cardiac involvement in college athletes much rarer than thoughtApril 23, 2021Heart FailureCOVID-19 UpdatesArrhythmias & EPCAD & Atherosclerosis
AHA statement on obesity emphasizes abdominal fat, AFibApril 22, 2021Heart FailureArrhythmias & EPLipid Disorders
Severe obesity persists, takes high cardiovascular tollApril 21, 2021Lipid DisordersHeart FailureCAD & AtherosclerosisDiversity in Medicine
Pneumonia risk soars in heart failure patients, especially HFpEFApril 19, 2021Heart FailureCOVID-19 Updates
Medtronic recall of almost 240,000 ICDs is class I, FDA saysApril 13, 2021Heart FailureArrhythmias & EP
Remote cardio visits expand access for underserved during COVIDApril 13, 2021Business of MedicineCOVID-19 UpdatesHypertensionHeart FailureArrhythmias & EPCAD & AtherosclerosisDiversity in Medicine
OCS heart system earns hard-won backing of FDA panelApril 12, 2021Heart FailureInterventional Cardiology & Surgery
Eating fish tied to fewer CVD events in high-risk peopleMarch 12, 2021CAD & AtherosclerosisAcute Coronary SyndromesHeart FailureLipid DisordersPreventive Care
Inpatient sodium imbalances linked to adverse COVID-19 outcomesMarch 11, 2021Heart FailureCOVID-19 Updates
Obesity: A ‘double hit’ in pregnant women with heart diseaseMarch 11, 2021CAD & AtherosclerosisArrhythmias & EPHeart FailurePreventive CareLipid Disorders
Semaglutide for meaningful weight loss in obesity and diabetes?March 9, 2021Heart FailureDiabetesLipid Disorders
Heart failure redefined with new classifications, stagingMarch 8, 2021Heart FailureDiabetesPreventive CareHypertension
More from DAPA-HF: Dapagliflozin quickly reduces heart failure eventsFebruary 22, 2021Heart FailureDiabetes
